Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 175 of 672 entries
View as:

Sofosbuvir Plus Ribavirin, or Ledipasvir/Sofosbuvir in Adults With HCV Infection and Renal Insufficiency

Phase: N/A Priority: Normal
NCT ID: NCT01958281 Org: User:
Start: 10/07/13 End: 10/19/17 Due: 10/19/18

Intended to Determine the Effects of Seladelpar on Normalization of Alkaline Phosphatase Levels in Subjects With Primary Biliary Cholangitis (PBC)

Phase: N/A Priority: Normal
NCT ID: NCT06060665 Org: User:
Start: 09/05/23 End: 06/30/26 Due: 06/30/27

Safety and Efficacy Study of MBX-102 in Treatment of Hyperuricemia in Patients With Gout

Phase: N/A Priority: Normal
NCT ID: NCT01336686 Org: User:
Start: 05/31/11 End: 11/30/11 Due: 11/30/12

A Study to Evaluate the Efficacy and Safety of Simtuzumab Combined With Gemcitabine for Metastatic Pancreatic Adenocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT01472198 Org: User:
Start: 11/30/11 End: 02/28/15 Due: 02/28/16

A Study on the Safety and Effectiveness of Adefovir Dipivoxil in Combination With Anti-HIV Therapy (HAART) in HIV-Positive Patients

Phase: N/A Priority: Normal
NCT ID: NCT00002426 Org: User:
Start: - End: - Due: -

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GS-5829 (Alobresib) as a Single Agent and In Combination With Enzalutamide in Participants With Metastatic Castrate-Resistant Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02607228 Org: User:
Start: 12/08/15 End: 09/03/19 Due: 09/03/20

Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed Dose Combination +/- Ribavirin in Adolescents and Children With Chronic HCV-Infection

Phase: N/A Priority: Normal
NCT ID: NCT02249182 Org: User:
Start: 11/05/14 End: 08/24/18 Due: 08/24/19

Study to Evaluate the Safety, Tolerability, and Antiviral Activity of Selgantolimod (Formerly GS-9688) in Viremic Adult Participants With Chronic Hepatitis B (CHB) Who Are Not Currently on Treatment

Phase: N/A Priority: Normal
NCT ID: NCT03615066 Org: User:
Start: 08/28/18 End: 04/12/21 Due: 04/12/22

Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Seladelpar in Subjects With Hepatic Impairment and Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03369002 Org: User:
Start: 11/27/17 End: 05/15/18 Due: 05/15/19

Pharmacokinetics of Eleclazine in Adults With Normal and Impaired Renal Function

Phase: N/A Priority: Normal
NCT ID: NCT02441829 Org: User:
Start: 05/31/15 End: 12/31/15 Due: 12/31/16

Study to Evaluate the Safety and Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir + Emtricitabine/Tenofovir Alafenamide in Human Immunodeficiency Virus (HIV-1) Infected, Antiretroviral Treatment-Naive Adults

Phase: N/A Priority: Normal
NCT ID: NCT02607956 Org: User:
Start: 11/11/15 End: 07/05/21 Due: 07/05/22

Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST Elevation Acute Coronary Syndromes

Phase: N/A Priority: Normal
NCT ID: NCT00099788 Org: User:
Start: 10/31/04 End: 02/28/07 Due: 02/28/08

Tenofovir Disoproxil Fumarate in HIV-Infected Patients Who Have Not Had Success With Other Anti-HIV Drug Combinations

Phase: N/A Priority: Normal
NCT ID: NCT00011089 Org: User:
Start: 02/28/01 End: - Due: -

Pharmacokinetics of Voxilaprevir in Adults With Normal Renal Function and Severe Renal Impairment

Phase: N/A Priority: Normal
NCT ID: NCT02402452 Org: User:
Start: 05/05/15 End: 09/28/15 Due: 09/28/16

Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate for Treatment of Hepatitis B e Antigen-Positive Hepatitis B (China)

Phase: N/A Priority: Normal
NCT ID: NCT02836249 Org: User:
Start: 06/19/15 End: 08/31/23 Due: 08/31/24

Study to Evaluate Safety, Pharmacokinetics, and Antiviral Activity of Bictegravir (GS-9883) in Human Immunodeficiency Virus (HIV)-1 Infected Participants

Phase: N/A Priority: Normal
NCT ID: NCT02275065 Org: User:
Start: 10/24/14 End: 01/29/15 Due: 01/29/16

Study of Obeldesivir to Treat Children With Respiratory Syncytial Virus (RSV) Infection

Phase: N/A Priority: Normal
NCT ID: NCT06784973 Org: User:
Start: 03/05/25 End: 04/16/25 Due: 04/16/26

A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection

Phase: N/A Priority: Normal
NCT ID: NCT01590654 Org: User:
Start: 04/30/12 End: 12/31/13 Due: 12/31/14

A Prospective, Observational Study of Individuals Who Seroconvert While Taking Truvada® for Pre-Exposure Prophylaxis (PrEP)

Phase: N/A Priority: Normal
NCT ID: NCT01902472 Org: User:
Start: 09/02/13 End: 10/30/17 Due: 10/30/18

A Registry for Participants With Cirrhosis Who Achieve a Sustained Virologic Response Following Treatment With a Sofosbuvir-Based Regimen Without Interferon for Chronic Hepatitis C Infection

Phase: N/A Priority: Normal
NCT ID: NCT02292706 Org: User:
Start: 12/29/14 End: 12/31/21 Due: 12/31/22

Study to Evaluate Switching From a Regimen Consisting of the Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate Single-Tablet Regimen (STR) to the Emtricitabine/Rilpivirine/Tenofovir Disoproxil Fumarate STR

Phase: N/A Priority: Normal
NCT ID: NCT01286740 Org: User:
Start: 01/31/11 End: 03/31/12 Due: 03/31/13

Safety Study of 90Y-hMN14 to Treat Colorectal Cancer Patients With Limited Residual Disease After Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00041691 Org: User:
Start: - End: - Due: -

Use-Results Surveillance Study of Sovaldi® Plus Copegus® in Japanese Patients With Chronic Genotype 2 Hepatitis C Virus Infection

Phase: N/A Priority: Normal
NCT ID: NCT02537379 Org: User:
Start: 09/15/15 End: 06/05/17 Due: 06/05/18

Open Label Study of Pharmacokinetics and Safety of Dose of Adefovir Dipivoxil in Children and Adolescents With HBV

Phase: N/A Priority: Normal
NCT ID: NCT00645294 Org: User:
Start: 02/28/03 End: 08/31/03 Due: 08/31/04

A Phase 2, Single-Arm, Open-Label Study Evaluating the Efficacy and Safety of Single Agent GS 1101 (CAL 101) as Therapy for Previously Treated Chronic Lymphocytic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT01659047 Org: User:
Start: 08/31/12 End: 12/31/15 Due: 12/31/16